HMOX1 and diabetes mellitus: Different studies revealed a potentiation of the pain-relieving activity of CB2R agonists through the co-administration of Nrf2 transcription factor activators or HO-1 enzyme inducers in animals with inflammatory pain and neuropathy associated with diabetes [47].